wla(warner lambert) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : wla(warner lambert)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Anthony Wong who wrote (615)	3/24/1999 11:53:00 PM
From: Brian Malloy	Read Replies (1) of 942

It's too late for Rezulin. The drug will probably not be pulled but the FDA will put some type of restrictions on it or mandate certain testing for patients using the drug. There are too many effective Diabetes products on the market that have a better safety profile. Additionally, two competitors will bring out drugs in the same class as Rezulin within the next few months. Unfortunately for WLA it appears that these new drugs due to not have this hepatic toxicity problem in selected patients and they don't require serial liver panels. That leaves WLA with Lipitor and whatever they can get from the AGPH buy out. I'm buying puts on WLA

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next